Business Wire Feed
Dentalcorp Announces Closing of Acquisition by Investment Funds Affiliated with GTCR
TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL) today announced the successful completion of the previously-announced statutory plan of arrangement (the “Arrangement”) whereby a newly formed acquisition vehicle affiliated with GTCR LLC (“GTCR”) more...
Quantum Computing Market Trends and Investment Opportunities 2025-2035 Featuring Profiles of 115 Companies – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Quantum Computing Market: Industry Trends and Global Forecasts - Distribution by Type of Drug Discovery Service Offered, Therapeutic Area and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering. The global quantum computing more...
Peptide Therapeutics Market Report 2025-2035: Industry to Experience Robust Growth with a CAGR of 6.8% Through 2035 – Subcutaneous Route to Command Over 65% Share – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Peptide Therapeutics Market: Industry Trends and Global Forecasts, Till 2040 - Distribution by Type of Peptide, Route of Administration, Key Therapeutic Area and Geographical Regions" has been added to ResearchAndMarkets.com's offering. The peptide more...
Survey results reveal why CUPE 4900 members rejected tentative deal and are planning Thursday rally
Newmarket, ON--(BUSINESS WIRE)--Paramedics, roads workers, public health workers, and other CUPE 4900 members will hold an information picket and rally outside of Thursday’s Committee of the Whole meeting. The picket sends a clear message that more...
Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference
Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, and alopecia areata, with 3 ongoing PoC/Phase II clinical studies* and 3 additional studies to be initiated in 2026. more...
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
Galderma will present data on Relfydess® (RelabotulinumtoxinA) – the first and only ready-to-use liquid neuromodulator designed with PEARL™ Technology – which further demonstrate its rapid onset and efficacy through 6 months in both moderate-to-severe frown more...
ScienceSoft to Present a Multi-Agent AI Taking Most Contact Center Tasks at WHX Dubai 2026
FUJAIRAH, United Arab Emirates--(BUSINESS WIRE)--#AgenticAI--ScienceSoft will speak at the World Health Expo (WHX) Dubai 2026, the event formerly known as Arab Health. On February 11, 2026, at 14:30 (UTC+4), Hadeel Abu Baker, Senior Healthcare IT more...
Zayed Sustainability Prize Honours Global Pioneers Advancing Progress
US$5.9M awarded to 11 organisations and high schools from the UAE, Brazil, Canada, Nepal, Switzerland, Uganda and across six sustainability categories From AI-enabled diagnostics to Cooling-as-a-Service, this year’s winners deliver locally adapted innovations that empower more...
Veracity Launches Metabolic Power Protein: A Smarter Protein Designed to Strengthen Your Metabolism Without Toxicity
NEW YORK--(BUSINESS WIRE)--Veracity, the leader in science-backed metabolic health solutions, today announced the launch of Metabolic Power Protein, a doctor-developed, plant-based protein designed to help people build lean, active muscle—the true engine of a healthy more...
Align Technology Sponsors 30 Invisalign® Treatments Through Smiles4Canada Program to Provide Orthodontic Care to Children and Teens
Sponsorship reflects commitment to increasing access to care for orthodontic treatment especially for children, and Align’s support of the Canadian orthodontic professionTEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that more...
Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate
The use of LuerVax® and Spray Divider™ support Aptar’s commitment to advancing drug delivery and next-generation vaccine development, backed by comprehensive regulatory and technical expertiseCRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in more...
Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting
Allele will generate mRNA reprogrammed cGMP iPSC lines; conduct R&D to differentiate iPSC into liver cells including hepatocytes, cholangiocytes, endothelial progenitors, hepatic stellate cells, etc.; manufacture cells at low cost and high yield aimed for more...
Rob Passaro Joins Orthopedic Care Partners as Business Development VP
Tenured Executive Joins Esteemed Group to Advance Disciplined Expansion and Long-Term ValueGAINESVILLE, Fla.--(BUSINESS WIRE)--Orthopedic Care Partners (OCP) welcomes Rob Passaro as Vice President of Business Development. His appointment supports OCP’s ongoing growth initiatives, strengthens its more...
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
Presents Business Update at J.P. Morgan Healthcare ConferenceATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN), one of the nation’s leading long-term care (“LTC”) pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary more...
ESTEVE to Acquire TerSera Therapeutics’ Infusion Specialty Therapies Business Unit, Expanding U.S. Presence
BARCELONA & DEERFIELD, Ill.--(BUSINESS WIRE)--ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera’s Infusion Specialty Therapies Business Unit (IST). This strategic acquisition enables ESTEVE more...
Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today shared an overview of its growing portfolio of eye care solutions including its more...
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The effort will leverage the NVIDIA more...
Charles River Laboratories Provides Business Updates
– Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 – more...
PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m., Pacific Time
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) announced today that Jason Murray, Chairman and Chief Executive Officer, and Mark Hancock, Executive Vice President and Interim Chief Financial Officer, will present at the annual J.P. more...
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a more...
SS&C to Release Fourth Quarter and Full Year 2025 Earnings
WINDSOR, Conn.--(BUSINESS WIRE)--SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services and healthcare software and software-enabled services, will announce its financial results for the fourth quarter and full year ended December 31, more...
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
New NeXT Personal® extension empowers clinicians to identify emerging resistance and therapeutically targetable mutations during disease monitoring and surveillanceFREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early more...
Viz.ai Closes 2025 with Record Scale and Patient Impact, Achieving Profitability in Its Healthcare Business while Accelerating Life Sciences Growth
Footprint grows to nearly 2,000 hospitals, and Life Sciences business doubles over the past 18 months, fueled by 6 new partnerships with top pharmaceutical companiesSAN FRANCISCO--(BUSINESS WIRE)--#ai--Viz.ai, the leader in AI-powered disease detection and intelligent more...
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Not intended for Canada-, UK- or US-based mediaDARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for more...
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient
STOCKHOLM--(BUSINESS WIRE)--At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics more...